Viewing Study NCT00225212


Ignite Creation Date: 2025-12-26 @ 11:13 PM
Ignite Modification Date: 2025-12-26 @ 11:13 PM
Study NCT ID: NCT00225212
Status: COMPLETED
Last Update Posted: 2014-09-15
First Post: 2005-09-21
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's Lymphoma
Sponsor: Stanford University
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 1997-11
Start Date Type: None
Primary Completion Date: 2003-03
Primary Completion Date Type: ACTUAL
Completion Date: 2003-03
Completion Date Type: ACTUAL
First Submit Date: 2005-09-21
First Submit QC Date: None
Study First Post Date: 2005-09-23
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2014-08-26
Results First Submit QC Date: None
Results First Post Date: 2014-09-05
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-09-04
Last Update Post Date: 2014-09-15
Last Update Post Date Type: ESTIMATED